Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
D000230:Adenocarcinoma / Q000139:chemically induced / Q000473:pathology; D000232:Adenofibroma / Q000139:chemically induced / Q000473:pathology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens; D055598:Chemical Phenomena; D002621:Chemistry; D004032:Diet; D005260:Female; D006834:Hydrazines / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000139:chemically induced / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced* / Q000473:pathology; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D009578:Nitrobenzenes / Q000008:administration & dosage; D009581:Nitrofurans / Q000008:administration & dosage; D051381:Rats; D012468:Salivary Gland Neoplasms / Q000139:chemically induced; D013160:Splenic Neoplasms / Q000139:chemically induced / Q000473:pathology; D013844:Thiazoles / Q000008:administration & dosage
D002273:Carcinogens; D006834:Hydrazines; D009578:Nitrobenzenes; D009581:Nitrofurans; D013844:Thiazoles